NFKB1 and psoriasis: One year later, Tatsuya Fukuta al. Combined AT1002 and IP to deliver NF-κB decoy oligonucleotides, and promoted macromolecular transfer through the synergic effect of weak current mediated intercellular junction cutting and AT1002s tight junction opening ability, thus achieving stronger intercellular space cutting and overcoming the skin barrier of psoriasis thickening.